Medicine, public health, drug approvals and health research. Each story is checked against its sources.
The FDA has approved AbbVie's Juvmo (tavapadon) to treat Parkinson's disease in adults. AbbVie says it is the first selective D1/D5 receptor agonist approved for the condition and expects US availability in October 2026.
The Ebola outbreak in the Democratic Republic of the Congo has passed 8,000 confirmed cases, with 3,901 deaths reported. No approved vaccine or specific treatment exists for the Bundibugyo strain.
At the second UN high-level meeting on pandemic prevention, preparedness and response, world leaders approved a political declaration. Talks continue on a pathogen-sharing annex to the WHO Pandemic Agreement.
The CDC is investigating an E. coli O26 outbreak linked to Graziers raw milk cheeses from Sierra Nevada Cheese Company. Thirteen people in nine states are sick, and over half are children 5 or younger.
The CDC and FDA are investigating a Salmonella outbreak linked to recalled broccoli sprouts from Evergreen Fresh Sprouts of Moyie Springs, Idaho. As of September 24, 32 people in six states were sick.
The World Health Organization released guidelines adding mifepristone as an emergency contraception option, backing extended use of combined pills and five-year use of implants, and setting out a profile for future male methods.
New CDC guidance dated September 23 recommends an updated COVID-19 vaccine for all adults. Some of the uses it describes fall outside the FDA's approvals, and the agency labels them off-label.
The CDC confirmed its first measles-related death of 2026 on September 23, amid a dispute with Pennsylvania over how many deaths to count. US cases reached 3,659 as of September 24.
Health Secretary Robert F. Kennedy Jr. appointed eight members to the panel whose recommendations decide which preventive services insurers must cover at no cost. The task force has not met in more than a year.
The FDA approved Ultragenyx's one-time gene therapy Fayuvi for children with Sanfilippo syndrome type A, a rare and fatal inherited brain disease. It is the first approved treatment for the condition.
